About IDEXX Laboratories, Inc. (IDXX)

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access a

IDXX Key Statistics

IDXX Price Performance

IDEXX Laboratories, Inc. stock has returned -4.59% over the past day, -6.33% over the past week, +0.28% over the past month, and -13.32% over the past three months. The stock trades between a 52-week low of $356.14 and a high of $769.98.

IDXX Financial Fundamentals

IDEXX Laboratories, Inc. reports a return on equity (ROE) of +66.20%, operating margin of +31.74%, profit margin of +2461.75%, and revenue growth of +14.30%. The debt-to-equity ratio is 0.61. Current ratio stands at 1.17.

IDXX Earnings

IDEXX Laboratories, Inc.'s next earnings report is expected on 2026-04-30 (56 days away). The company has a +1.00% earnings beat rate with an average surprise of +4.78%. Earnings consistency is rated as "high".

IDXX Ownership

Institutional investors hold approximately +0.96% of IDXX shares across 10 institutions. Insider ownership is +0.01%. Insider sentiment is "bearish".

IDXX Short Interest

IDXX has a short interest of +2.88% of float with a short ratio (days to cover) of 3.3.

IDXX AI Analysis Signal

iGotFomo's AI-powered signal engine rates IDXX as "LEAN SELL" with LOW confidence (score: 28/100). 4 signals are bullish, 7 are bearish, and 2 are neutral.